Hisamitsu Pharmaceutical Co., Inc. (HTSUY) Research

Hisamitsu Pharmaceutical Co., Inc. is a company dedicated to the entire lifecycle of healthcare products, from initial research and development to manufacturing and global distribution of pharmaceuticals and related health solutions. It is particularly recognized for its well-known brands such as Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat. Beyond these, Hisamitsu's diverse portfolio encompasses prescription-only medicines, over-the-counter remedies, medical devices, nutritional supplements, and a range of topical products designed for pain relief. Established by Nihei Hisamitsu in 1847, the company maintains its corporate headquarters in Tosu, Japan.

Market snapshot

Symbol
HTSUY
Price
$2.94
Day change
0.00%
Market cap
$425.2B
P/E ratio
22.44x
52-week range
2.94-9.42
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • EBOS Group Limited (EBOSY)
  • Elekta AB (publ) (EKTAF)
  • Elekta AB (publ) (EKTAY)
  • Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
  • Embla Medical hf. (OSSFF)
  • Rest Ez Inc. (RTEZ)
  • Redcare Pharmacy N.V. (SAEYY)
  • Redcare Pharmacy N.V. (SHPPF)

Open Hisamitsu Pharmaceutical Co., Inc. (HTSUY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.